Trial · NCT00567359
Adverse events50
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 50
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hemoglobin | Blood and lymphatic system disorders | Erlotinib | 5 | 100 | 7 |
| other | Leukocytes | Investigations | Erlotinib | 5 | 100 | 5 |
| other | Fatigue | General disorders | Erlotinib | 63 | 100 | 92 |
| other | Dry skin | Skin and subcutaneous tissue disorders | Erlotinib | 49 | 100 | 68 |
| other | Alopecia | Skin and subcutaneous tissue disorders | Erlotinib | 19 | 100 | 19 |
| other | Nail changes | Skin and subcutaneous tissue disorders | Erlotinib | 27 | 100 | 40 |
| other | Pruritus/itching | Skin and subcutaneous tissue disorders | Erlotinib | 24 | 100 | 34 |
| other | Rash/desquamation | Skin and subcutaneous tissue disorders | Erlotinib | 22 | 100 | 38 |
| other | Rash: acne/acneiform | Skin and subcutaneous tissue disorders | Erlotinib | 74 | 100 | 163 |
| other | Erythema multiforme | Skin and subcutaneous tissue disorders | Erlotinib | 8 | 100 | 11 |
| other | Skin-other | Skin and subcutaneous tissue disorders | Erlotinib | 26 | 100 | 35 |
| other | Anorexia | Metabolism and nutrition disorders | Erlotinib | 13 | 100 | 18 |
| other | Constipation | Gastrointestinal disorders | Erlotinib | 15 | 100 | 22 |
| other | Diarrhea w/o prior colostomy | Gastrointestinal disorders | Erlotinib | 74 | 100 | 120 |
| other | Dry mouth | Gastrointestinal disorders | Erlotinib | 5 | 100 | 5 |
| other | Dyspepsia | Gastrointestinal disorders | Erlotinib | 10 | 100 | 14 |
| other | Muco/stomatitis by exam, oral cavity | Gastrointestinal disorders | Erlotinib | 20 | 100 | 31 |
| other | Nausea | Gastrointestinal disorders | Erlotinib | 31 | 100 | 44 |
| other | Taste disturbance | Gastrointestinal disorders | Erlotinib | 8 | 100 | 9 |
| other | Vomiting | Gastrointestinal disorders | Erlotinib | 11 | 100 | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00567359/events